The Union

WHO Global TB Symposium

Room: Auditorium I

Beyond 2015: Ramping Up to End TB

The end of 2015 marks a transition from the Millennium Development Goals (MDGs) to the Sustainable Development Goals (SDGs), including ending the TB epidemic. As envisioned in the WHO End TB Strategy, driving down TB deaths, incidence and eliminating catastrophic costs requires better care and prevention, bolder policies and systems and bigger investments in research and innovation.

2015 has been a year of continued scale-up of key interventions to address all forms of TB, including drug-resistant TB, HIV-associated TB and for all people affected, including men, women and children, persons with co-morbidities and all poor and marginalised groups at special risk. It has also been a year of planning for further acceleration across the three pillars of the End TB Strategy, involving the range of stakeholders, and actions to overcome bottlenecks.

This year’s one-day Global TB Symposium, organised by the World Health Organization, focuses on key stakeholders and their collective actions to revamp and intensify their efforts to meet new End TB targets.

Objectives of the symposium:

  1. To offer participants an overview of the achievement on the Millennium Development Goal of halting and reversing the TB epidemic, and status on achievement of other 2015 targets.
  2. To highlight the steps being taken to prepare to implement the End TB Strategy and fundamental links to other Sustainable Development Goals for 2030.
  3. To discuss the actions being taken by groups of stakeholders, from politicians to global health leaders, TB programme managers, civil society actors and researchers, in pursuing better care and prevention, bolder policies and systems and bigger investments in research and innovation.
  4. To profile some recent advances in TB research.
I. Opening
Mr José Luis Castro, Executive Director, The Union
In Memoriam
Highlights of a year preparing for the post-2015 era
Dr Mario Raviglione, Director, Global TB Programme, World Health Organization (WHO)
Dr Eric Goosby, UN Special Envoy on TB
Progress in the TB response: The Global TB Report 2015
Dr Katherine Floyd, Coordinator, WHO Global TB Programme
II. Keynote Address: Ending TB within the Sustainable Development Goals Agenda
Dr Winnie Mpanju-Shumbusho, Assistant Director-General, World Health Organization
III. Driving Rapid Uptake of the End TB Strategy
Chair: Dr Eric Goosby, UN Special Envoy on TB
Launch of new fixed-dose combination for better TB treatment for children
Dr Mel Spigelman, CEO, TB Alliance
Dr Philippe Duneton, Deputy Director, UNITAID
Monique Davids, South Africa
Next steps for programmes: results of the 2015 national TB programme managers’ summit on the End TB Strategy
High TB Burden National TB Programme Summit Spokesperson
Next steps for NGOs and CSOS: results of WHO consultation on NGO and CSO engagement in the End TB Strategy
Ms Lucy Chesire, TB Advocacy Consortium, Kenya, spokesperson for the participants in the consultation
Next steps for political commitment: results of the 2nd meeting of the Global TB Caucus of parliamentarians
Rt Hon Nick Herbert, Member of Parliament, United Kingdom and Co-Chair of the Global TB Caucus
Questions and comments
IV. Adopting New Policies
Chairs: Dr Kitty van Weezenbeek, and Ms Diana Weil, WHO Global TB Programme
Results of a survey of 24 countries on new TB policy adoption
Dr Grania Brigden, MSF Access Campaign
Panel: Overcoming policy adoption bottlenecks
Dr Anshu Prakash, Ministry of Health & Family Welfare, India
Dr Charles Sandy, Ministry of Health, Zimbabwe
Mr Anele Yawa, Treatment Action Campaign
Questions and comments
Coffee break
V. Panel: Making the Case for National TB Research Investment
Chairs: Dr Richard Menzies, McGill University and Dr Christian Lienhardt, WHO Global TB Programme

Dr Afranio Kritski, University of Rio de Janeiro; Dr Frank Cobelens, KNCV TB Foundation; Dr Lelisa Fekadu, Ministry of Health, Ethiopia; Dr Gilla Kaplan, Bill & Melinda Gates Foundation
Questions and comments
VI. Panel: 2015 Advances in TB Research
Chairs: Dr Valerie Mizrahi, University of Cape Town and Dr Guy Marks, University of Sydney

Dr Willem Hanekom, Bill & Melinda Gates Foundation; Dr Madhu Pai, McGill University; Dr Manica Balasegaram, MSF Treatment Access Campaign
Questions and comments
VII. Summing Up: Next Steps 2016
Dr Mario Raviglione and Dr Eric Goosby

Topics Legend

CLH = Child TB & Lung Health

CS = Civil Society


LH = Lung Health


NCDs = Non-Communicable Diseases

NAPs = Nursing & Allied Professions

TC = Tobacco Control

TB = Tuberculosis

ZOO = Zoonotic TB

RES = Research